Home - Australian Pharmacist

James Chalmers and Peter Guthrey MPS - August 9, 2000

Industry

Pharmacy practice is rapidly evolving. Here’s how the drastically reimagined Professional Practice Standards can help the profession adapt.

SGLT2 inhibitors in heart failure

AP Staff - February 20, 2000

CPD

References McDonagh T, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart...

Changes to AIR information – DO NOT USE

AP Staff - April 18, 2000

Clinical

Pruritus in adult palliative care patients

AP Staff - November 7, 2000

Clinical

References Chaing HC, Huang V, Cornelius LA. Cancer and itch. Seminars in cutaneous medicine and surgery 2011;30(2):107–12. Weisshaar E, Dalgard F. Epidemiology of itch:...

Supporting environmental sustainability – what can you do to help?

AP Staff - December 12, 2000

Advertorial

Advice and practical tips on how pharmacists can help lead positive change. How are climate change and health connected? Healthcare may not be the first thing...

Cardiovascular risk: have we been getting our sums wrong?

Ruth Cooper - March 6, 2000

Clinical

References AusCVDRisk. How the calculator was developed. At: www.cvdcheck.org.au/how-the-calculator-was-developed Heart Foundation. Game-changing new approach to stopping cardiovascular disease before it strikes. 2023. At: www.heartfoundation.org.au/media-releases/new-approach-prevention-of-cardiovascular-disease ...

1...291292293...295 Page 292 of 295

What does ‘patient identification’ mean?

Why does the identification process often fail?

What are the consequences?

How do you trace a mix-up?

How can process issues be addressed?

Keep following protocols until further notice

National harmonisation would make clinical updates much easier

PSA’s guidance will change

Pharmacists dispensing antibiotics must use their professional clinical judgement

There are other key changes pharmacists need to know

Is Australia at risk of losing control over measles spread?

What’s driving the surge in measles cases?

How can pharmacists promote the importance of vaccination?

Who is eligible for a catch-up dose?

How important is vaccination prior to travel?

What nerve pain conditions does pregabalin actually help?

Who is a good candidate for deprescribing?

How should deprescribing be approached?

How should you broach a conversation about deprescribing?

Who is more likely to have withdrawal issues?

What does ‘patient identification’ mean?

Why does the identification process often fail?

What are the consequences?

How do you trace a mix-up?

How can process issues be addressed?

Keep following protocols until further notice

National harmonisation would make clinical updates much easier

PSA’s guidance will change

Pharmacists dispensing antibiotics must use their professional clinical judgement

There are other key changes pharmacists need to know

Is Australia at risk of losing control over measles spread?

What’s driving the surge in measles cases?

How can pharmacists promote the importance of vaccination?

Who is eligible for a catch-up dose?

How important is vaccination prior to travel?

What nerve pain conditions does pregabalin actually help?

Who is a good candidate for deprescribing?

How should deprescribing be approached?

How should you broach a conversation about deprescribing?

Who is more likely to have withdrawal issues?

What does ‘patient identification’ mean?

Why does the identification process often fail?

What are the consequences?

How do you trace a mix-up?

How can process issues be addressed?

Keep following protocols until further notice

National harmonisation would make clinical updates much easier

PSA’s guidance will change

Pharmacists dispensing antibiotics must use their professional clinical judgement

There are other key changes pharmacists need to know

Is Australia at risk of losing control over measles spread?

What’s driving the surge in measles cases?

How can pharmacists promote the importance of vaccination?

Who is eligible for a catch-up dose?

How important is vaccination prior to travel?

What nerve pain conditions does pregabalin actually help?

Who is a good candidate for deprescribing?

How should deprescribing be approached?

How should you broach a conversation about deprescribing?

Who is more likely to have withdrawal issues?

What does ‘patient identification’ mean?

Why does the identification process often fail?

What are the consequences?

How do you trace a mix-up?

How can process issues be addressed?

Keep following protocols until further notice

National harmonisation would make clinical updates much easier

PSA’s guidance will change

Pharmacists dispensing antibiotics must use their professional clinical judgement

There are other key changes pharmacists need to know

Is Australia at risk of losing control over measles spread?

What’s driving the surge in measles cases?

How can pharmacists promote the importance of vaccination?

Who is eligible for a catch-up dose?

How important is vaccination prior to travel?

What nerve pain conditions does pregabalin actually help?

Who is a good candidate for deprescribing?

How should deprescribing be approached?

How should you broach a conversation about deprescribing?

Who is more likely to have withdrawal issues?